Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller
Psychemedics Corporation (NASDAQ: PMD) has appointed Andrew Limbek as Vice President, Controller.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Psychemedics Corporation (NASDAQ: PMD) has appointed Andrew Limbek as Vice President, Controller. Andrew brings over 12 years of experience in financial activities, including external reporting and internal analysis. He has worked with prominent accounting advisory firms and held operational roles, including Controller at Racepoint Global, Inc. His educational background includes a Bachelor of Science in Accounting from the University of New Hampshire. CEO Raymond C. Kubacki emphasizes Andrew's technical expertise and financial analysis skills as pivotal for the company’s growth strategy.
Positive
- Appointment of Andrew Limbek as Vice President, Controller enhances the financial leadership team.
- Andrew's extensive experience in accounting and financial analysis supports the company's growth strategy.
Negative
- None.
Details
News Market Reaction – PMD
The recorded move for PMD in the trading session of this news was +34.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller.
In this important role, Andrew will be responsible for directing and managing all of the Company’s financial activities including external reporting and internal analysis. He will report directly to the Company’s CEO.
As an active CPA, Andrew joins the Company with over 12 years-experience and a very strong accounting technical background, having worked at three high level accounting advisory firms. In addition, Andrew has had several operational roles including role of Controller at Racepoint Global, Inc., an international, independent professional services agency. Most recently, Andrew has been a consultant as a financial planning and analysis Director at a publicly-held biotech company. Andrew graduated from University of New Hampshire with a Bachelor of Science degree in Accounting.
Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated “We are extremely pleased to have Andrew joining our team and heading up this important area in our Company. Andrew’s strong technical accounting background and experience are very important as we address today’s increasingly complex accounting world. In addition, his significant financial analysis skills and background will be a great contribution to the Company’s growth strategy and plans. We are excited to have him on board.”
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over
Contact: Raymond C. Kubacki, Chairman, President and CEO
Phone: (978) 206-8220
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.